BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38659169)

  • 1. Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z-CAN) in Puerto Rico, 2016-2020.
    Zapata LB; Kortsmit K; Curtis KM; Romero L; Hurst S; Lathrop E; Acosta Perez E; Sánchez Cesáreo M; Whiteman MK
    Stud Fam Plann; 2024 Jun; 55(2):105-125. PubMed ID: 38659169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
    Lathrop E; Romero L; Hurst S; Bracero N; Zapata LB; Frey MT; Rivera MI; Berry-Bibee EN; Honein MA; Monroe J; Jamieson DJ
    Lancet Public Health; 2018 Feb; 3(2):e91-e99. PubMed ID: 29371100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Program Fidelity and Patient Satisfaction among Women Served by the Zika Contraception Access Network Program in Puerto Rico.
    Zapata LB; Romero L; Rivera MI; Rivera-Soto SK; Hurst S; Mendoza ZV; Clayton HB; Bracero N; Whiteman MK; Lathrop E
    Womens Health Issues; 2020; 30(4):268-276. PubMed ID: 32376188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting reversible contraception use and unmet desire among patients after the Zika Contraception Access Network Program in Puerto Rico.
    Stewart A; Romero L; Kortsmit K; Hurst S; Powell R; Lathrop E; Whiteman MK; Zapata LB
    Contraception; 2024 Jul; 135():110441. PubMed ID: 38552819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
    Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
    Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Public-Private Partnerships to Increase Access to Contraception in an Emergency Response Setting: The Zika Contraception Access Network Program.
    Romero L; Mendoza ZV; Croft L; Bhakta R; Sidibe T; Bracero N; Malave C; Suarez A; Sanchez L; Cordero D; Lathrop E; Monroe J
    J Womens Health (Larchmt); 2020 Nov; 29(11):1372-1380. PubMed ID: 33196331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of contraceptive use in Puerto Rico during the 2016 Zika virus outbreak.
    Ellington SR; Rodriguez RS; Goldberg H; Bertolli J; Simeone RM; Mercado AS; Pazol K; Jamieson DJ; Honein MA; Swartzendruber A; Miles T; Cordero JF; Shapiro-Mendoza CK
    Contraception; 2020 Jun; 101(6):405-411. PubMed ID: 32194040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016.
    Tepper NK; Goldberg HI; Bernal MI; Rivera B; Frey MT; Malave C; Renquist CM; Bracero NJ; Dominguez KL; Sanchez RE; Shapiro-Mendoza CK; Rodriguez BR; Simeone RM; Pesik NT; Barfield WD; Ko JY; Galang RR; Perez-Padilla J; Polen KN; Honein MA; Rasmussen SA; Jamieson DJ
    MMWR Morb Mortal Wkly Rep; 2016 Apr; 65(12):311-4. PubMed ID: 27031817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of the Zika Virus, Contraceptive Access, and Motivation to Participate in the Zika Contraception Access Network Program: Qualitative Analysis of Focusgroup Discussions with Puerto Rican Women.
    Romero L; Acosta-Pérez E; Bednar H; Hurst S; Zapata LB; Vega-Torres S; Powell R; Lathrop E
    P R Health Sci J; 2024 Mar; 43(1):46-53. PubMed ID: 38512761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to Contraceptive Services in Puerto Rico: An Analysis of Policy and Practice Change Strategies, 2015-2018.
    Romero L; Corrada-Rivera RM; Huertas-Pagan X; Aquino-Serrano FV; Morales-Boscio AM; Sanchez-Cesareo M; Acosta-Perez E; Mendoza Z; Lathrop E
    J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E506-E517. PubMed ID: 33729201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician and clinic staff attitudes and practices during implementation of the Zika Contraception Access Network.
    Tepper NK; Zapata LB; Hurst S; Curtis KM; Lathrop E; Romero L; Acosta-Perez E; Mendoza Z; Whiteman MK
    Contraception; 2020 Jul; 102(1):34-38. PubMed ID: 32298716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016-17 Zika virus outbreak.
    Li R; Ellington SR; Galang RR; Grosse SD; Mendoza Z; Hurst S; Vale Y; Lathrop E; Romero L
    Contraception; 2022 Mar; 107():68-73. PubMed ID: 34748752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community Understanding of Contraception During the Zika Virus Outbreak in Puerto Rico.
    August EM; Rosenthal J; Torrez R; Romero L; Berry-Bibee EN; Frey MT; Torres R; Rivera-García B; Honein MA; Jamieson DJ; Lathrop E
    Health Promot Pract; 2020 Jan; 21(1):133-141. PubMed ID: 31142152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants.
    Simmons RG; Sanders JN; Geist C; Gawron L; Myers K; Turok DK
    Am J Obstet Gynecol; 2019 Apr; 220(4):376.e1-376.e12. PubMed ID: 30576664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Health Communication Campaign on Uptake of Contraceptive Services during the 2016-2017 Zika Virus Outbreak in Puerto Rico.
    August EM; Powell R; Morris E; Romero L; Zapata LB; Lathrop E
    Health Commun; 2023 Feb; 38(2):252-259. PubMed ID: 34182847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception as a Medical Countermeasure to Reduce Adverse Outcomes Associated With Zika Virus Infection in Puerto Rico: The Zika Contraception Access Network Program.
    Romero L; Koonin LM; Zapata LB; Hurst S; Mendoza Z; Lathrop E;
    Am J Public Health; 2018 Sep; 108(S3):S227-S230. PubMed ID: 30192658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints.
    Romero L; Mendoza Z; Hurst S; Zapata LB; Powell R; Vale Y; Lathrop E
    Contraception; 2020 Nov; 102(5):356-360. PubMed ID: 32858052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do women discontinue contraception and what are the post-discontinuation outcomes? Evidence from the Arusha Region, Tanzania.
    Sato R; Elewonibi B; Msuya S; Manongi R; Canning D; Shah I
    Sex Reprod Health Matters; 2020 Dec; 28(1):1723321. PubMed ID: 32178594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016.
    Li R; Simmons KB; Bertolli J; Rivera-Garcia B; Cox S; Romero L; Koonin LM; Valencia-Prado M; Bracero N; Jamieson DJ; Barfield W; Moore CA; Mai CT; Korhonen LC; Frey MT; Perez-Padilla J; Torres-Muñoz R; Grosse SD
    Emerg Infect Dis; 2017 Jan; 23(1):74-82. PubMed ID: 27805547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.